National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 77650 [2010-31181]
Download as PDF
77650
Federal Register / Vol. 75, No. 238 / Monday, December 13, 2010 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Adherence Studies
in Adolescents with Chronic Diseases:
Kidney, Urologic or Diabetes (R01).
Date: January 10, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Najma Begum, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Translational
Research in Diabetes and Obesity.
Date: January 25, 2011.
Time: 7 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Michele L. Barnard, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 7, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–31182 Filed 12–10–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trails.
Date: January 6, 2011.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call)
Contact Person: Lakshmi Ramachandra,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
Room 2217, 6700–B Rockledge Drive, MSC–
7616, Bethesda, MD 20892–7616, 301–496–
2550, Ramachandral@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 7, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–31181 Filed 12–10–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5374–N–22]
Buy American Exceptions Under the
American Recovery and Reinvestment
Act of 2009
Office of the Assistant
Secretary for Public and Indian
Housing, HUD.
ACTION: Notice.
AGENCY:
BILLING CODE 4140–01–P
In accordance with the
American Recovery and Reinvestment
SUMMARY:
VerDate Mar<15>2010
15:42 Dec 10, 2010
Jkt 223001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Act of 2009 (Pub. L. 111–05, approved
February 17, 2009) (Recovery Act), and
implementing guidance of the Office of
Management and Budget (OMB), this
notice advises that certain exceptions to
the Buy American requirement of the
Recovery Act have been determined
applicable for work using Capital Fund
Recovery Formula and Competition
(CFRFC) grant funds. Specifically, an
exception was granted to the Chicago
Housing Authority for the purchase and
installation of microwave ovens and
Ground Fault Circuit Interrupter (GFCI)
outlets for the Kenmore Apartments
project.
FOR FURTHER INFORMATION CONTACT:
Dominique G. Blom, Deputy Assistant
Secretary for Public Housing
Investments, Office of Public Housing
Investments, Office of Public and Indian
Housing, Department of Housing and
Urban Development, 451 7th Street,
SW., Room 4130, Washington, DC
20410–4000, telephone number 202–
402–8500 (this is not a toll-free
number). Persons with hearing- or
speech-impairments may access this
number through TTY by calling the tollfree Federal Information Relay Service
at 800–877–8339.
SUPPLEMENTARY INFORMATION: Section
1605(a) of the Recovery Act provides
that none of the funds appropriated or
made available by the Recovery Act may
be used for a project for the
construction, alteration, maintenance, or
repair of a public building or public
work unless all of the iron, steel, and
manufactured goods used in the project
are produced in the United States.
Section 1605(b) provides that the Buy
American requirement shall not apply
in any case or category in which the
head of a Federal department or agency
finds that: (1) Applying the Buy
American requirement would be
inconsistent with the public interest; (2)
iron, steel, and the relevant
manufactured goods are not produced in
the U.S. in sufficient and reasonably
available quantities or of satisfactory
quality, or (3) inclusion of iron, steel,
and manufactured goods will increase
the cost of the overall project by more
than 25 percent. Section 1605(c)
provides that if the head of a Federal
department or agency makes a
determination pursuant to section
1605(b), the head of the department or
agency shall publish a detailed written
justification in the Federal Register.
In accordance with section 1605(c) of
the Recovery Act and OMB’s
implementing guidance published on
April 23, 2009 (74 FR 18449), this notice
advises the public that, on November
23, 2010, upon request of the Chicago
E:\FR\FM\13DEN1.SGM
13DEN1
Agencies
[Federal Register Volume 75, Number 238 (Monday, December 13, 2010)]
[Notices]
[Page 77650]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-31181]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trails.
Date: January 6, 2011.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference Call)
Contact Person: Lakshmi Ramachandra, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217,
6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-
2550, Ramachandral@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 7, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-31181 Filed 12-10-10; 8:45 am]
BILLING CODE 4140-01-P